Questions discussed in this category
Given poor pulmonary outcomes in people with anti-PL12 antibodies, would you recommend more aggressive therapy? The patient was diagnosed with onset o...
Would you consider belimumab over a TNF inhibitor for inflammatory arthritis? Which agent would be more beneficial for the lung disease?
18771175991830314695
Papers discussed in this category
The Lancet. Respiratory medicine, 2016-09
Respirology, 2013 Nov 29
Respir Res, 2022 Jun 21
Arthritis & rheumatology (Hoboken, N.J.), 2015-05
International journal of rheumatic diseases, 2014-02
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2014-04-18
Clinical nuclear medicine, 2016-05
J Investig Med High Impact Case Rep, 2021 Jan-Dec
Clinical therapeutics, 2018 Feb
Seminars in arthritis and rheumatism, 2018 Jan 06
Lancet Respir Med, 2023 Jan